Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database.
|アブストラクト||This study used data from a large-scale multicenter medical information database in Japan to estimate the incidence rate of herpes zoster (HZ) and to examine the relationship between hypertension, dyslipidemia, and diabetes mellitus (DM), and the risk of HZ among patients with rheumatoid arthritis (RA). The research dataset consisted of 221,196 records of potential target patients with RA extracted between April 1, 2008 and August 31, 2017 from the Medical Data Vision database. To assess the association between hypertension, dyslipidemia, and DM and the risk of HZ, a case-control study was set up. Records of 101,498 study subjects met the inclusion criteria. During the observation period, 2566 patients developed HZ and the overall incidence rate was 5.2 (95% confidence interval: 5.0-5.4 per 1000 patient-years). Hypertension, dyslipidemia, and DM were significantly associated with an increased risk of HZ after adjustment for sex, age, hospital size, and use of anti-rheumatic drugs. When mutual adjustment was made for hypertension, dyslipidemia, and DM, the positive associations between hypertension and dyslipidemia and the risk of HZ remained significant; however, the positive association with DM completely disappeared. RA patients with hypertension or dyslipidemia may be at higher risk of HZ.|
|投稿者||Tanaka, Keiko; Kimura, Eizen; Oryoji, Kensuke; Mizuki, Shin-Ichi; Kobayashi, Tomoko; Nishikawa, Atsushi; Yoshinaga, Eiko; Miyake, Yoshihiro|
|組織名||Department of Epidemiology and Preventive Medicine, Ehime University Graduate;School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.;email@example.com.;Research Promotion Unit, Translation Research Center, Ehime University Hospital,;Ehime, Japan. firstname.lastname@example.org.;Center for Data Science, Ehime University, Ehime, Japan.;National Institute of Public Health, Saitama, Japan.;Department of Medical Informatics, Ehime University Graduate School of Medicine,;Ehime, Japan.;Center for Rheumatic Diseases, Matsuyama Red Cross Hospital, Matsuyama, Ehime,;Japan.;Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K, Hyogo,|